<unk> (oral) is an antifungal triazole that is FDA approved for the treatment of invasive aspergillosis, candidemia in non-neutropenic patients, esophageal candidiasis, serious fungal infections caused by scedosporium apiospermum and fusarium spp, including fusarium solani, in Patients intolerant of, or Refractory to, other therapy.   Common adverse reactions include visual disturbances, fever, nausea, rash, vomiting, chills, headache, abnormal liver function test, tachycardia, and hallucinations.
Voriconazole 
Fluconazole 
Amphotericin B
Ipriflavone
Miconazole 
Bifonazole
Terbinafine 
Efinaconazole